Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
Advances in Oto-Rhino-Laryngology|April 4, 2019
Systemic Therapy, Palliation and Supportive Care of Patients with Hypopharyngeal CancerPatrick J Bradley, Thorsten Füreder, Hans E EckelWiener Klinische Wochenschrift|December 9, 2020
Molecularly guided treatment of metastatic parotid gland carcinoma in adultsHossein Taghizadeh, Leonhard Müllauer, Robert M Mader, et al.Hamostaseologie|June 9, 2026
Risk Factors, Biomarkers, and Risk Assessment Models for Prediction of Venous Thromboembolism in Ambulatory Patients with Advanced Lung CancerLeyla Ay, Florian Moik, Thorsten Füreder, et al.Head & Neck|October 9, 2012
Safety and feasibility of every-other-week maintenance cetuximab after first-line chemotherapy in patients with recurrent or metastatic head and neck squamous cell cancerPaolo Bossi, Gabriela Kornek, Gaetano Lanzetta, et al.Journal of Cranio-Maxillo-Facial Surgery : Official Publication of the European Association for Cranio-Maxillo-Facial Surgery|February 22, 2021
An analysis of distant metastasis cases from HPV-associated oropharyngeal squamous cell carcinomaFaris F Brkic, Lorenz Kadletz-Wanke, Lukas Kenner, et al.Clinical Journal of Oncology Nursing|March 19, 2016
A Cross-Sectional Study of Patients' Satisfaction With Totally Implanted Access PortsChristoph Minichsdorfer, Thorsten Füreder, Bruno Mähr, et al.Histopathology|May 10, 2018
PD-1 and PD-L1 expression in HNSCC primary cancer and related lymph node metastasis - impact on clinical outcomeSven Schneider, Lorenz Kadletz, Robert Wiebringhaus, et al.Wiener Klinische Wochenschrift|November 4, 2017
Review of cancer treatment with immune checkpoint inhibitors : Current concepts, expectations, limitations and pitfallsChristiane Thallinger, Thorsten Füreder, Matthias Preusser, et al.European Journal of Cancer (Oxford, England : 1990)|May 22, 2021
Docetaxel, cisplatin and 5-FU compared with docetaxel, cisplatin and cetuximab as induction chemotherapy in advanced squamous cell carcinoma of the head and neck: Results of a randomised phase II AGMT trialFelix Keil, Maximilian Hartl, Gabriela Altorjai, et al.Wiener Klinische Wochenschrift|July 21, 2012
[Therapy of castration-resistant prostate cancer]Michael Rauchenwald, Thomas Bauernhofer, Maria De Santis, et al.Pageof 2